San Diego-based biotherapeutics company aTyr Pharma is focused on discovering and developing novel immunological pathways for the creation of new medicines. Its lead candidate, efzofitimod, is currently in Phase III clinical trials for the treatment of pulmonary sarcoidosis and in Phase 1b/2a clinical trials for other interstitial lung diseases, including chronic hypersensitivity pneumonitis and connective tissue disease-related ILD. The company is also developing ATYR2810, a fully humanized monoclonal antibody for the treatment of solid tumors in preclinical development. aTyr Pharma has a collaboration and license agreement with Kyorin Pharmaceutical for the development and commercialization of efzofitimod for ILDs in Japan. The company was founded in 2005.
Lifecare's ticker is LIFE
The company's shares trade on the NASDAQ stock exchange
They are based in San Diego, California
There are 51-200 employees working at Lifecare
It is lifecare.no
Lifecare is in the Healthcare sector
Lifecare is in the Biotechnology industry
The following five companies are Lifecare's industry peers: